tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Maravai LifeSciences Holdings Inc

MRVI
Add to Watchlist
6.570USD
-0.180-2.67%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.70BMarket Cap
LossP/E TTM

Maravai LifeSciences Holdings Inc

6.570
-0.180-2.67%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

MRVI Financials

See Maravai LifeSciences Holdings Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Maravai LifeSciences Holdings Inc Earnings Date

Latest Release
Aug 6, 2026
EPS / Forecast
--/-0.04
Revenue / Forecast
--/48.68M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
185.74M
-28.34%
EPS(YoY)
-0.91
13.75%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
87.79%-0.03
-33.42%-0.25
74.75%-0.18
-280.92%-0.27
-128.76%-0.21
77.01%-0.18
-1328.42%-0.70
-45.28%-0.07
-17796.08%-0.09
-380.45%-0.80
---0.05
---0.05
--0.00
--0.29
--1.39
----
----
----
----
----
Revenue
40.53%65.84M
-11.59%49.87M
-36.15%41.63M
-35.43%47.40M
-27.00%46.85M
-23.92%56.41M
-2.49%65.20M
6.51%73.40M
-18.79%64.18M
-63.78%74.14M
-65.04%66.86M
-71.61%68.91M
-67.65%79.03M
-10.39%204.71M
-6.61%191.26M
11.46%242.73M
64.83%244.29M
132.27%228.44M
--204.81M
--217.78M
Net Profit
87.53%-3.73M
-36.47%-35.68M
74.20%-25.56M
-421.96%-39.59M
-147.93%-29.95M
75.33%-26.14M
-1432.62%-99.04M
-15.96%-7.58M
-17926.87%-12.08M
-381.55%-105.96M
-114.53%-6.46M
-109.18%-6.54M
-100.10%-67.00K
-32.12%37.63M
-17.59%44.47M
44.96%71.24M
189.42%66.86M
137.37%55.44M
--53.96M
--49.14M
Net Margin
91.41%-9.69%
-53.31%-126.37%
59.89%-108.23%
-455.33%-147.34%
-219.23%-112.81%
44.43%-82.43%
-1094.86%-269.87%
-53.10%-26.53%
-1971.69%-35.34%
-447.34%-148.34%
---22.59%
---17.33%
---1.71%
--42.71%
--59.45%
----
----
----
----
----
Gross Margin
210.44%51.19%
-23.39%25.75%
-68.79%13.58%
-63.11%16.39%
-59.05%16.49%
-36.15%33.62%
-3.58%43.52%
19.40%44.42%
-29.83%40.27%
-28.84%52.65%
--45.13%
--37.21%
--57.39%
--73.99%
--82.94%
----
----
----
----
----
Debt to assets ratio
13.06%38.48%
28.87%41.90%
-11.90%38.17%
-5.33%36.28%
-11.52%34.04%
-13.12%32.51%
76.18%43.33%
55.36%38.32%
63.89%38.47%
61.94%37.42%
--24.59%
--24.67%
--23.47%
--23.11%
--23.49%
----
----
----
----
----
Income Statement
Revenue
40.53%65.84M
-11.59%49.87M
-36.15%41.63M
-35.43%47.40M
-27.00%46.85M
-23.92%56.41M
-2.49%65.20M
6.51%73.40M
-18.79%64.18M
-63.78%74.14M
-65.04%66.86M
-71.61%68.91M
-67.65%79.03M
-10.39%204.71M
-6.61%191.26M
11.46%242.73M
64.83%244.29M
132.27%228.44M
--204.81M
--217.78M
Operating profit
112.08%4.06M
24.06%-18.46M
-162.96%-32.50M
-261.87%-33.51M
-96.18%-33.63M
-7743.71%-24.31M
-37.06%-12.36M
6.11%-9.26M
-294.83%-17.14M
-99.72%318.00K
-107.53%-9.02M
-105.60%-9.86M
-94.92%8.80M
-25.39%113.31M
-16.77%119.67M
15.35%176.00M
88.19%173.33M
386.04%151.86M
--143.79M
--152.58M
Net Profit
87.53%-3.73M
-36.47%-35.68M
74.20%-25.56M
-421.96%-39.59M
-147.93%-29.95M
75.33%-26.14M
-1432.62%-99.04M
-15.96%-7.58M
-17926.87%-12.08M
-381.55%-105.96M
-114.53%-6.46M
-109.18%-6.54M
-100.10%-67.00K
-32.12%37.63M
-17.59%44.47M
44.96%71.24M
189.42%66.86M
137.37%55.44M
--53.96M
--49.14M
Balance Sheet
Current assets
-33.10%251.74M
-30.97%296.25M
-52.01%325.87M
-47.51%359.76M
-43.66%376.28M
-38.69%429.15M
-3.11%679.10M
-1.99%685.36M
-12.75%667.88M
-17.45%699.91M
-16.12%700.87M
-7.91%699.31M
23.64%765.51M
14.58%847.90M
21.53%835.53M
17.83%759.38M
45.49%619.13M
123.17%740.04M
193.64%687.48M
--644.49M
Total current liabilities
-32.52%42.62M
-21.16%44.92M
-2.64%61.57M
1.65%69.68M
7.01%63.16M
-34.87%56.97M
-19.18%63.24M
-8.50%68.55M
-52.74%59.02M
-20.59%87.47M
-32.34%78.25M
-33.42%74.92M
44.10%124.90M
17.45%110.14M
1.14%115.66M
-31.71%112.53M
-47.55%86.67M
-28.29%93.78M
-59.23%114.35M
--164.77M
Total assets
-25.69%713.22M
-23.57%770.58M
-33.56%849.19M
-38.04%896.97M
-33.56%959.75M
-32.22%1.01B
-43.63%1.28B
-36.07%1.45B
-37.61%1.44B
-34.83%1.49B
0.83%2.27B
4.27%2.26B
13.32%2.32B
18.98%2.28B
18.70%2.25B
35.63%2.17B
51.15%2.04B
50.96%1.92B
156.69%1.89B
--1.60B
Total liabilities
-19.87%344.13M
-7.70%397.87M
-37.25%417.33M
-36.09%428.98M
-35.63%429.48M
-38.21%431.04M
-51.64%665.09M
-50.89%671.19M
-52.84%667.25M
-49.34%697.57M
-2.27%1.38B
-2.23%1.37B
1.86%1.41B
0.30%1.38B
-2.35%1.41B
10.24%1.40B
21.62%1.39B
23.03%1.37B
105.25%1.44B
--1.27B
Total equity
-30.40%369.08M
-35.43%372.71M
-29.56%431.86M
-39.73%467.98M
-31.79%530.27M
-26.92%577.21M
-31.29%613.13M
-13.50%776.41M
-13.68%777.39M
-12.74%789.88M
6.01%892.28M
16.01%897.64M
37.65%900.64M
65.99%905.24M
85.55%841.67M
132.27%773.79M
211.93%654.30M
252.42%545.36M
1160.25%453.62M
--333.14M
Cash Flow Statement
Net operating income
192.28%8.66M
-55.54%-22.77M
-215.33%-15.15M
-158.88%-10.27M
-10.90%-9.39M
-287.91%-14.64M
-7.27%13.14M
-9.17%17.43M
-109.95%-8.47M
-92.16%7.79M
-87.13%14.17M
-88.32%19.19M
-47.58%85.07M
70.78%99.33M
4.26%110.06M
-1.00%164.28M
323.48%162.30M
-17.07%58.17M
--105.56M
--165.94M
Net investment
80.82%-4.44M
57.13%-2.11M
67.34%-2.93M
47.65%-3.24M
-444.98%-23.13M
61.78%-4.93M
42.27%-8.96M
74.41%-6.18M
93.91%-4.24M
30.33%-12.90M
-165.44%-15.52M
-1354.36%-24.16M
71.14%-69.73M
-227.09%-18.52M
-104.93%-5.85M
63.36%-1.66M
-8577.59%-241.58M
36.02%-5.66M
--118.63M
---4.53M
Net financing
-1027.06%-55.23M
99.23%-1.82M
-1119.65%-8.25M
-772.81%-1.53M
-775.00%-4.90M
-50352.98%-236.19M
3.32%809.00K
100.53%228.00K
97.08%-560.00K
100.71%470.00K
102.09%783.00K
0.64%-43.13M
52.60%-19.21M
-34.95%-66.12M
26.99%-37.44M
-27.20%-43.41M
-68.44%-40.52M
-198.06%-49.00M
---51.28M
---34.13M

FAQs

What is the total revenue of Maravai LifeSciences Holdings Inc?

According to Maravai LifeSciences Holdings Inc's FY2025 earnings report, its total revenue reached 185.74M, with a year-on-year change of 259.19M.

What are the current assets of Maravai LifeSciences Holdings Inc?

According to Maravai LifeSciences Holdings Inc's FY2025 earnings report, its current assets were 296.25M, with a year-on-year change of -30.97.

What are the total assets of Maravai LifeSciences Holdings Inc?

According to Maravai LifeSciences Holdings Inc's FY2025 earnings report, its total assets of Maravai LifeSciences Holdings Inc were 770.58M, with a year-on-year change of -23.57.

What are the total liabilities of Maravai LifeSciences Holdings Inc?

According to Maravai LifeSciences Holdings Inc's FY2025 earnings report, its total liabilities of Maravai LifeSciences Holdings Inc were 397.87M, with a year-on-year change of -7.70.

What is the total equity of Maravai LifeSciences Holdings Inc?

According to Maravai LifeSciences Holdings Inc's FY2025 earnings report, its total equity of Maravai LifeSciences Holdings Inc was 372.71M, with a year-on-year change of -35.43.

What is the net operating income of Maravai LifeSciences Holdings Inc?

According to Maravai LifeSciences Holdings Inc's FY2025 earnings report, its net operating income of Maravai LifeSciences Holdings Inc was -117.04M, with a year-on-year change of -85.58.

What is the net investment of Maravai LifeSciences Holdings Inc?

According to Maravai LifeSciences Holdings Inc's FY2025 earnings report, its net investment of Maravai LifeSciences Holdings Inc was -31.41M, with a year-on-year change of -29.15.

What is the net financing of Maravai LifeSciences Holdings Inc?

According to Maravai LifeSciences Holdings Inc's FY2025 earnings report, its net financing of Maravai LifeSciences Holdings Inc was -16.50M, with a year-on-year change of 93.00.

What is the Earnings Per Share (EPS) of Maravai LifeSciences Holdings Inc?

According to Maravai LifeSciences Holdings Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.91, with a year-on-year change of 13.75.

What is the net income of Maravai LifeSciences Holdings Inc?

According to Maravai LifeSciences Holdings Inc's FY2025 earnings report, its net income was -130.77M, with a year-on-year change of 9.72.

What is the net margin of Maravai LifeSciences Holdings Inc?

According to Maravai LifeSciences Holdings Inc's FY2025 earnings report, its net profit margin was -124.24, with a year-on-year change of -24.03.

What is the gross margin of Maravai LifeSciences Holdings Inc?

According to Maravai LifeSciences Holdings Inc's FY2025 earnings report, its gross margin was 18.30, with a year-on-year change of -56.21.

What is the debt-to-asset ratio of Maravai LifeSciences Holdings Inc?

According to Maravai LifeSciences Holdings Inc's FY2025 earnings report, its debt-to-asset ratio was 41.90, with a year-on-year change of 28.87.

What is the Return on Equity (ROE) of Maravai LifeSciences Holdings Inc?

According to Maravai LifeSciences Holdings Inc's FY2025 earnings report, its Return on Equity (ROE) was -48.64, with a year-on-year change of -24.60.

What is the Return on Assets (ROA) of Maravai LifeSciences Holdings Inc?

According to Maravai LifeSciences Holdings Inc's FY2025 earnings report, its Return on Assets (ROA) was -25.95, with a year-on-year change of -24.70.

What is the operating profit of Maravai LifeSciences Holdings Inc?

According to Maravai LifeSciences Holdings Inc's FY2025 earnings report, its operating profit was -117.04M, with a year-on-year change of -85.58.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy